ABBVon logo

AbbVie Inc (ABBV)

AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta to treat bl...

NYSEHealthcareDrug Manufacturers - GeneralUSA

Company Profile

Stock Code
ABBV
ISIN Code
US00287Y1091
Currency
US Dollar (USD)
IPO Date
2013-01-02

Contact Information

Company Address
1 North Waukegan Road, North Chicago, IL, United States, 60064-6400
Contact Phone
847 932 7900
Company Website
https://www.abbvie.com
Fiscal Year End
December

Financial Highlights

Market Capitalization
$999,999.99
Gross Profit (TTM)
$999,999.99
Dividend Yield
3.15%
Return on Assets (TTM)
10.03%
EBITDA
$999,999.99
Revenue (TTM)
$999,999.99